10 May 2023 : Clinical Research
Surgical Outcomes in 62 Patients with Ulcerative Colitis: A Retrospective, Single-Center Study from Poland
Zofia Kampka
1BDEF*, Marek Zielonka 1ABD, Marta Kozikowska 1BEF, Grzegorz Wypych1AB, Patryk Zemła 1CD, Beata Jabłońska 2ADE, Sławomir Mrowiec 2AF
DOI: 10.12659/MSM.939412
Med Sci Monit 2023; 29:e939412
Table 1 Baseline characteristics.
| n (%) orMean±SD | 95% lower bound CI, 95% upper bound CI | ||
|---|---|---|---|
| Male | 36 (58.1%) | ||
| Female | 26 (41.9%) | ||
| Age | 52.69±16.84 | 48.42, 56.97 | |
| BMI [kg/m] | 23.10±5.50 | 21.45, 24.75 | |
| Overweight | 8 (12.9%) | ||
| Obesity | 5 (8.1%) | ||
| Malnutrition | 13 (21.0%) | ||
| Parenteral nutrition | 5 (8.1%) | ||
| Comorbidities | Diabetes mellitus | 5 (8.1%) | |
| Hypertension | 9 (14.5%) | ||
| Other CVD | 11 (17.7%) | ||
| Hypothyroidism | 2 (3.2%) | ||
| Current smoker | 4 (6.5%) | ||
| Anaemia | 17 (68.0%) | ||
| Hypoalbuminemia | 12 (92.3%) | ||
| Diagnosis | Ulcerative colitis, unspecified | 21 (34.4%) | |
| Other ulcerative colitis | 13 (21.3%) | ||
| Ulcerative ileocolitis | 10 (16.4%) | ||
| Ulcerative rectosigmoiditis | 8 (13.1%) | ||
| Ulcerative pancolitis | 4 (6.6%) | ||
| Left sided colitis | 3 (4.9%) | ||
| Inflammatory polyps of colon | 1 (1.6%) | ||
| Ulcerative proctitis | 1 (1.6%) | ||
| Time from diagnosis to surgery [years] | 5.68±6.04 | 3.5, 7.82 | |
| Surgery length [hours] | 5.29±1.61 | 4.43, 6.15 | |
| Total hospitalization time [days] | 17.46±11.55 | 14.18, 20.74 | |
| Pharmacological treatment prior to surgery | 5-ASA | 33 (53.2%) | |
| Mesalazine | 19 (30.6%) | ||
| Sulfasalazine | 14 (22.6%) | ||
| Glucocorticosteroids | 37 (59.7%) | ||
| Biological therapy | 7 (11.3%) | ||
| Immunosuppressive drugs | 24 (38.7%) | ||
| Urgent surgery | 21 (36.2%) | ||
| Elective surgery | 37 (63.8%) | ||
| Postoperative complications | 25 (40.3%) | ||
| Postoperative complications | Wound suppuration | 14 (22.6%) | |
| Wound dehiscence | 6 (9.7%) | ||
| Intra-abdominal hemorrhage | 4 (6.5%) | ||
| Sepsis | 3 (4.8%) | ||
| Anastomotic leaks | 1 (1.6%) | ||
| Intestinal obstruction | 1 (1.6%) | ||
| Relaparotomy | 14 (22.6%) | ||
| Rehospitalization | 2 (3.2%) | ||
| Mortality | 8 (12.9%) | ||
| Data are presented as number and percentage (in brackets) of patients or mean±standard deviation (SD) and 95% confidence interval (CI) – lower and upper bound. BMI – body mass index; CVD – cardiovascular disease; 5-ASA – 5-aminosalicylic acid derivatives. | |||